RETEVMO 160 mg/1 (Selpercatinib TABLET, COATED) 160 mg/1

RETEVMO 160 mg tablets are a prescription medication used for targeted therapy. This oral treatment is designed to address specific conditions related to genetic mutations.

Strength

160 mg/1

Pack Size

60 TABLET, COATED in 1 BOTTLE (0002-5562-60)

Manufacturer / TM Owner

Eli Lilly and Company

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

RETEVMO 160 mg tablets are primarily used for targeted therapy in conditions associated with specific genetic mutations. Selpercatinib, the active ingredient, is often prescribed for its potential to interfere with the growth of abnormal cells. Patients may wonder, 'What is RETEVMO used for?' This medication is typically utilized in cases where standard treatments may not be effective.

Side Effects

Common effects of RETEVMO 160 mg tablets may include gastrointestinal issues, fatigue, and changes in taste. Some users might experience dizziness or swelling. It's important to note that individual responses can vary, and not everyone will experience these effects.

Precautions & Warnings

RETEVMO 160 mg tablets should be handled with care. Store the medication in a cool, dry place away from direct sunlight. Always follow the prescription label instructions and consult a healthcare provider before making any changes to your medication regimen.

Avoid Interactions

RETEVMO 160 mg tablets may interact with certain medications, including those that affect liver enzymes. It's advisable to avoid alcohol while taking this medication. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.

Frequently Asked Questions

RETEVMO is used for targeted therapy in conditions related to specific genetic mutations.

Store RETEVMO tablets in a cool, dry place away from direct sunlight.

Common effects may include gastrointestinal issues, fatigue, and changes in taste.

It is advisable to avoid alcohol while taking RETEVMO to prevent potential interactions.

If you miss a dose, consult your healthcare provider for guidance on when to take the next dose.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.